Journal
MEDICAL MYCOLOGY
Volume 49, Issue -, Pages S7-S12Publisher
OXFORD UNIV PRESS
DOI: 10.3109/13693786.2010.505204
Keywords
Aspergillus; clinical risk factors; invasive aspergillosis
Categories
Ask authors/readers for more resources
Despite improvements in the antifungal armamentarium and diagnostic modalities, invasive aspergillosis (IA) remains an important cause of morbidity and mortality in immunocompromised patients. There is an emergence of non-traditional groups at risk for IA, including intensive care unit (ICU) patients, post-operative patients, those with chronic pulmonary diseases, patients with AIDS and patients on immunomodulating drugs (TNF-alpha inhibitors). Identification of clinical risk factors for IA may help in determining which patients require risk modification and other prevention measures.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available